Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (221-230 of 359) with videos related to

Pageof 36
Sort By:
Frontiers in Aging Neuroscience|October 25, 2021
Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer's Disease and ControlsMandy Melissa Jane Wittens, Gert-Jan Allemeersch, Diana Maria Sima, et al.
Brain : a Journal of Neurology|March 1, 2011
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohortJulie van der Zee, Tim Van Langenhove, Gernot Kleinberger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitorMaarten Timmers, Bianca Van Broeck, Steven Ramael, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar DegenerationJoery Goossens, Jorne Laton, Jeroen Van Schependom, et al.
Journal of Neuropathology and Experimental Neurology|February 27, 2021
Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets NeurodegenerationAnne Sieben, Tim Van Langenhove, Yannick Vermeiren, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Neurobiology of Aging|January 29, 2013
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairmentRita Cacace, Caroline Van Cauwenberghe, Karolien Bettens, et al.
Alzheimer'S Research & Therapy|May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADCKristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Acta Neuropathologica|March 13, 2014
Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosisJulia K Götzl, Kohji Mori, Markus Damme, et al.
Journal of Neurochemistry|January 11, 2016
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseasesLinda J C van Waalwijk van Doorn, Marleen J Koel-Simmelink, Ute Haußmann, et al.
Pageof 36

Showing results (221-230 of 359) with videos related to

Sort By:
Pageof 36
Frontiers in Aging Neuroscience|October 25, 2021
Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer's Disease and ControlsMandy Melissa Jane Wittens, Gert-Jan Allemeersch, Diana Maria Sima, et al.
Brain : a Journal of Neurology|March 1, 2011
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohortJulie van der Zee, Tim Van Langenhove, Gernot Kleinberger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitorMaarten Timmers, Bianca Van Broeck, Steven Ramael, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar DegenerationJoery Goossens, Jorne Laton, Jeroen Van Schependom, et al.
Journal of Neuropathology and Experimental Neurology|February 27, 2021
Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets NeurodegenerationAnne Sieben, Tim Van Langenhove, Yannick Vermeiren, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Neurobiology of Aging|January 29, 2013
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairmentRita Cacace, Caroline Van Cauwenberghe, Karolien Bettens, et al.
Alzheimer'S Research & Therapy|May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADCKristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Acta Neuropathologica|March 13, 2014
Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosisJulia K Götzl, Kohji Mori, Markus Damme, et al.
Journal of Neurochemistry|January 11, 2016
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseasesLinda J C van Waalwijk van Doorn, Marleen J Koel-Simmelink, Ute Haußmann, et al.
Pageof 36